Park Dental Partners, Inc. (PARK)
NASDAQ:PARK
Want to see PARK full AI Analyst Report?
Top Page
Park Dental Partners, Inc.
(NASDAQ:PARK)
Select Model
Select Model
Rating:57Neutral
Price Target:
$19.00
▲(9.64% Upside)
Action:Reiterated
Date:05/19/26
The score is primarily weighed down by weak profitability and historically high balance-sheet risk (negative equity/leverage), partially offset by consistently positive cash generation. Technicals are modestly favorable (price above key moving averages with positive MACD), while valuation is unattractive due to a negative P/E and no dividend. The latest earnings call supports the outlook with steady growth and maintained guidance, but GAAP profitability headwinds persist.
Positive Factors
Consistent cash generation
Park Dental reports positive operating cash flow and free cash flow across annual periods, improving into 2024. Durable cash generation funds operations, supports integration of acquisitions, and provides internal capital for reinvestment, lowering reliance on external funding despite moderate coverage vs. debt.
Negative Factors
Historical negative equity / high leverage
Historic negative equity and elevated leverage materially weaken the balance sheet and complicate leverage metrics. The large 2025 step-change reduces trend comparability, increases covenant and creditor sensitivity, and constrains financial flexibility to absorb shocks or fund opportunistic investments without taxable or dilutive financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent cash generation
Park Dental reports positive operating cash flow and free cash flow across annual periods, improving into 2024. Durable cash generation funds operations, supports integration of acquisitions, and provides internal capital for reinvestment, lowering reliance on external funding despite moderate coverage vs. debt.
Read all positive factors
Park Dental Partners, Inc. (PARK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$84.16M
Dividend YieldN/A
Average Volume (3M)96.30K
Price to Earnings (P/E)―
Beta (1Y)0.18
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees1,208
SectorHealthcare
Sector Strength45
IndustryMedical - Equipment & Services
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,515,054
10 Day Avg. Volume61,908
30 Day Avg. Volume96,297
Financial Highlights & Ratios
PEG Ratio0.69
Price to Book (P/B)1.32
Price to Sales (P/S)0.12
P/FCF Ratio2.79
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit2.38
Enterprise Value/Ebitda16.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.09
Revenue Forecast (FY)$256.60M
Park Dental Partners, Inc. Business Overview & Revenue Model
Company Description
Park Dental Partners, Inc. operates as a dental resource organization that offers business support services to dentists throughout Minnesota and Wisconsin. The company's services include provision of clinical team members, administrative personnel...
How the Company Makes Money
null...
Park Dental Partners, Inc. Earnings Call Summary
Earnings Call Date:May 13, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Mar 03, 2027
Earnings Call Sentiment Positive
The call conveyed solid operational momentum with mid-single-digit revenue growth (6.2% YoY), healthy same-practice growth (4.1%), positive adjusted EBITDA and cash flow, a strong patient retention rate (>90%), and a robust M&A pipeline and balance sheet. Near-term GAAP profitability is pressured by elevated share-based compensation (IPO vesting acceleration), higher public company costs, and a larger share count that depresses GAAP EPS versus prior year. Management maintained full-year guidance and emphasized continued investments in capacity and disciplined M&A. Overall, positive operational and liquidity indicators outweigh the near-term GAAP expense headwinds and seasonality risks.Positive Updates
Revenue Growth
Q1 revenue of $62.7M, representing 6.2% year-over-year growth, driven by organic patient demand and provider base expansion.
Negative Updates
GAAP Net Loss and EPS Decline
GAAP net loss of $0.4M (loss of $0.09 per share) in Q1 2026 versus net income of $1.6M ($0.88 per share) in Q1 2025, reflecting higher GAAP expenses post-IPO and share recognition timing.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth
Q1 revenue of $62.7M, representing 6.2% year-over-year growth, driven by organic patient demand and provider base expansion.
Read all positive updates
Company Guidance
Park Dental maintained its full‑year 2026 outlook after a Q1 that produced $62.7M of revenue (up 6.2% YoY) with same‑practice revenue growth of 4.1%, general practice revenue of $46.1M (+6.4%) and multi‑specialty revenue of $16.6M (+5.7%); adjusted EBITDA was $4.7M (7.6% margin) and adjusted EPS $0.44, while GAAP showed a net loss of $0.4M (‑$0.09/sh) versus prior‑year Q1 net income of $1.6M ($0.88/sh). The company ended the quarter with $24.4M of cash, $11.5M of total debt, an undrawn $15M revolver, and $5M of operating cash flow; it has 221 doctors across three states and patient retention just over 90%. Management said elevated share‑based compensation (about 91% attributable to doctor shareholders) and public‑company costs are expected post‑IPO but will decline as accelerated vesting is recognized, reiterated that M&A is the primary growth lever (with de novos a smaller driver), plans to enter 2–3 new markets over the next few years, and expects Q2 revenue growth to be lower than Q1 with Q3–Q4 tracking at or above Q1 as seasonal hiring and year‑end/early‑year acquisitions are integrated into the second half.Park Dental Partners, Inc. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
22
Negative
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 246.17M | 244.49M | 229.79M | 223.51M |
| Gross Profit | 30.73M | 32.16M | 34.13M | 27.34M |
| EBITDA | 4.53M | 12.34M | 17.50M | 10.57M |
| Net Income | -2.82M | -358.00K | -8.66M | -2.28M |
Balance Sheet | ||||
| Total Assets | 179.86M | 197.03M | 154.52M | 155.12M |
| Cash, Cash Equivalents and Short-Term Investments | 24.37M | 25.18B | 2.67M | 558.00K |
| Total Debt | 59.75M | 60.35M | 62.16M | 61.05M |
| Total Liabilities | 154.42M | 175.23M | 158.82M | 157.41M |
| Stockholders Equity | 25.44M | 21.80M | -4.30M | -2.29M |
Cash Flow | ||||
| Free Cash Flow | 2.73B | 10.29M | 10.31M | 3.83M |
| Operating Cash Flow | 5.04B | 17.63M | 16.47M | 13.05M |
| Investing Cash Flow | -4.78B | -10.65M | -7.67M | -14.05M |
| Financing Cash Flow | -1.05B | 15.53M | -6.68M | 465.00K |
Park Dental Partners, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $3.19B | 18.02 | 46.05% | 1.27% | 15.46% | 12.13% | |
68 Neutral | $21.40B | 23.18 | 10.91% | 1.14% | 7.34% | 30.39% | |
62 Neutral | $3.72B | 55.92 | 2.18% | ― | 12.15% | ― | |
59 Neutral | $146.70M | -1.63 | -35.14% | ― | -9.29% | 46.89% | |
57 Neutral | $84.16M | -29.51 | -23.93% | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $56.31M | -0.29 | -88.97% | ― | -42.03% | -28904.55% |
* Healthcare Sector Average
PARK
Park Dental Partners, Inc.
18.96
8.71
84.98%
LH
Labcorp Holdings
265.15
13.83
5.50%
NVST
Envista Holdings
23.10
4.37
23.33%
AMWL
American Well
8.62
1.66
23.85%
DCGO
DocGo
0.56
-0.97
-63.46%
CON
Concentra Group Holdings Parent, Inc.
25.32
3.48
15.92%
Park Dental Partners, Inc. Corporate Events
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Park Dental Amends Credit Facility Following IPO Transition
Positive
Feb 19, 2026
On February 13, 2026, effective January 1, 2026, Park Dental Partners and its affiliated borrower entities amended their existing credit agreement with U.S. Bank National Association, which provides a $15 million revolving line of credit and a $13...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.